BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.

作者: Hakan Alakus , Shawn E Yost , Brian Woo , Randall French , Grace Y Lin

DOI: 10.1186/S12967-015-0485-1

关键词: MesotheliomaCopy number analysisPathologyBAP1Exome sequencingChromosome 3CDKN2APeritoneal Malignant MesotheliomaPeritoneal NeoplasmMedicine

摘要: Malignant mesothelioma (MM) arises from mesothelial cells that line the pleural, peritoneal and pericardial surfaces. The majority of MMs are pleural have been associated with asbestos exposure. Previously, genetically characterized by loss BAP1 (40-60%) as well NF2 (75%) CDKN2A (60%). rare form MM occurs in ~10% cases. With only ~300 cases diagnosed US per year, its link to exposure is not clear mutational landscape unknown. We analyzed somatic 12 epitheloid subtype using copy number analysis (N = 9), whole exome sequencing (N = 7) targeted (N = 12). Peritoneal display few alterations, most samples having less than 10 Mbp total changes, mostly through deletions no high amplification. Chromosome band 3p21 encoding recurrently deleted region (5/9), while, contrast MM, affected. further identified 87 non-silent mutations across 7 sequenced tumors, a median 8 mutated genes tumor, resulting very low mutation rate (median 1.3 10−6). was gene (N = 3/7). In one additional case, entire chromosome 3 leaves non-functional carrying nonsense germline variant, thus suggesting potential genetic predisposition this patient. Finally, cases, we conclude frequently altered losses (N = 3/12), (N = 3/12) or both (N = 2/12) sometimes at sub-clonal level. Our findings suggest major role for susceptibility oncogenesis indicate important molecular differences strategies therapy prevention.

参考文章(34)
Alessio Bridda, Mauro Frego, Roberto Mencarelli, Ilaria Padoan, Peritoneal mesothelioma: a review. MedGenMed : Medscape general medicine. ,vol. 9, pp. 32- ,(2007)
Sheng Xiao, J. M. Corson, D. J. Sugarbaker, J. A. Fletcher, J. Vijg, Daizong Li, CODELETION OF P15 AND P16 IN PRIMARY MALIGNANT MESOTHELIOMA Oncogene. ,vol. 11, pp. 511- 515 ,(1995)
Yasunori Enomoto, Takahiko Kasai, Maiko Takeda, Masato Takano, Kouhei Morita, Eiji Kadota, Norishige Iizuka, Hiroshi Maruyama, Joji Haratake, Yu Kojima, Naoya Ikeda, Akitaka Nonomura, A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma. Pathology International. ,vol. 62, pp. 226- 231 ,(2012) , 10.1111/J.1440-1827.2011.02778.X
K H Antman, E A Pomfret, J Aisner, J MacIntyre, R T Osteen, J S Greenberger, Peritoneal mesothelioma: natural history and response to chemotherapy. Journal of Clinical Oncology. ,vol. 1, pp. 386- 391 ,(1983) , 10.1200/JCO.1983.1.6.386
K. Wang, M. Li, H. Hakonarson, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data Nucleic Acids Research. ,vol. 38, ,(2010) , 10.1093/NAR/GKQ603
Michael J. Bamshad, Joshua M. Akey, , , , Jacob A. Tennessen, Abigail W. Bigham, Timothy D. O’Connor, Wenqing Fu, Eimear E. Kenny, Simon Gravel, Sean McGee, Ron Do, Xiaoming Liu, Goo Jun, Hyun Min Kang, Daniel Jordan, Suzanne M. Leal, Stacey Gabriel, Mark J. Rieder, Goncalo Abecasis, David Altshuler, Deborah A. Nickerson, Eric Boerwinkle, Shamil Sunyaev, Carlos D. Bustamante, Evolution and functional impact of rare coding variation from deep sequencing of human exomes Science. ,vol. 337, pp. 64- 69 ,(2012) , 10.1126/SCIENCE.1219240
A. B. Bianchi, S. I. Mitsunaga, J. Q. Cheng, W. M. Klein, S. C. Jhanwar, B. Seizinger, N. Kley, A. J. Klein-Szanto, J. R. Testa, High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 10854- 10858 ,(1995) , 10.1073/PNAS.92.24.10854
Matthew Bott, Marie Brevet, Barry S Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard A Lake, Maureen F Zakowski, Boris Reva, Chris Sander, Robert Delsite, Simon Powell, Qin Zhou, Ronglai Shen, Adam Olshen, Valerie Rusch, Marc Ladanyi, The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma Nature Genetics. ,vol. 43, pp. 668- 672 ,(2011) , 10.1038/NG.855
Joseph R Testa, Mitchell Cheung, Jianming Pei, Jennifer E Below, Yinfei Tan, Eleonora Sementino, Nancy J Cox, A Umran Dogan, Harvey I Pass, Sandra Trusa, Mary Hesdorffer, Masaki Nasu, Amy Powers, Zeyana Rivera, Sabahattin Comertpay, Mika Tanji, Giovanni Gaudino, Haining Yang, Michele Carbone, Germline BAP1 mutations predispose to malignant mesothelioma Nature Genetics. ,vol. 43, pp. 1022- 1025 ,(2011) , 10.1038/NG.912
Michael S Lawrence, Petar Stojanov, Paz Polak, Gregory V Kryukov, Kristian Cibulskis, Andrey Sivachenko, Scott L Carter, Chip Stewart, Craig H Mermel, Steven A Roberts, Adam Kiezun, Peter S Hammerman, Aaron McKenna, Yotam Drier, Lihua Zou, Alex H Ramos, Trevor J Pugh, Nicolas Stransky, Elena Helman, Jaegil Kim, Carrie Sougnez, Lauren Ambrogio, Elizabeth Nickerson, Erica Shefler, Maria L Cortés, Daniel Auclair, Gordon Saksena, Douglas Voet, Michael Noble, Daniel DiCara, Pei Lin, Lee Lichtenstein, David I Heiman, Timothy Fennell, Marcin Imielinski, Bryan Hernandez, Eran Hodis, Sylvan Baca, Austin M Dulak, Jens Lohr, Dan-Avi Landau, Catherine J Wu, Jorge Melendez-Zajgla, Alfredo Hidalgo-Miranda, Amnon Koren, Steven A McCarroll, Jaume Mora, Ryan S Lee, Brian Crompton, Robert Onofrio, Melissa Parkin, Wendy Winckler, Kristin Ardlie, Stacey B Gabriel, Charles WM Roberts, Jaclyn A Biegel, Kimberly Stegmaier, Adam J Bass, Levi A Garraway, Matthew Meyerson, Todd R Golub, Dmitry A Gordenin, Shamil Sunyaev, Eric S Lander, Gad Getz, None, Mutational heterogeneity in cancer and the search for new cancer-associated genes Nature. ,vol. 499, pp. 214- 218 ,(2013) , 10.1038/NATURE12213